Font Size: a A A
Keyword [The human lung adenocarcinoma]
Result: 1 - 15 | Page: 1 of 1
1. Development Of A 2', 2-Difluorodeoxycytide(Gemcitabine)-resistant Variant Of The Human Lung Adenocarcinoma Cell Line A549 And Study On The Mechanism Of Drug Resistance
2. The Human Lung Adenocarcinoma Multidrug Resistant Cell Cloning And Preliminary Identification Of Differentially Expressed Genes In
3. Studies Of The Effects Of The Tachyplesin On The Human Lung Adenocarcinoma SPC-A-1 Cells
4. Studies Of The Differentiation Effect Induced By BPO-L On The Human Lung Adenocarcinoma A549 Cells
5. Chemosensitivity Effects And Mitochondria Mechanisms Study On The Human Lung Adenocarcinoma Cell Line A549
6. Study On Anti-tumor Effects And Its Mechansim Of Ampelopsin Sodium Combined With Carboplatin On The Human Lung Adenocarcinoma GLC-82 Cells
7. Honokiol In Combination With A Low Dose Oxaliplatin Can Induced Apoptosis Of The Human Lung Adenocarcinoma A549 Cells
8. Purification Of Heat Shock Protein 70 Peptide Complex Drived From Human Lung Adenocarcinoma And The Effect On The Human Lung Adenocarcinoma Cell Line A549
9. The Effect Of The Expression Of Interleukin13Receptor α2(IL-13Rα2) Induced By Interleukin13in The Human Lung Adenocarcinoma Cell A549
10. The Study On Induction Of The Epithelial-mesenchymal Transition Of The Human Lung Adenocarcinoma By Lactate Acid
11. High-dose Gefitinib Pulsatile Overcome The Human Lung Adenocarcinoma PC9/GR Cells In Vitro
12. The Expression And Significance Of PTEN、mTOR And AICARFT In The Human Lung Adenocarcinoma Cancer Cell Line A549 Pemetrexed Resistance A549/PEM
13. Anti-tumor Effects Of Iso-suillin From Suillus Flavus On The Human Lung Adenocarcinoma A549 Cells In Vitro And In Vivo
14. Study Of The Mechanism Of Yifei Jiedu Formula And Ddp Synergetic Effect On Human Lung Adenocarcinoma A549 Line Cells
15. Effectof Metformin Butyrate On The Proliferation,apoptosis And Mobility Of The Human Lung Adenocarcinoma A549 Cells And Its Relationship With PEDF Expression
  <<First  <Prev  Next>  Last>>  Jump to